Associations of aspirin, statins and metformin with lung cancer risk and related mortality

Given the poor survival of lung cancer patients and the promising observations herein, future studies (RCTs) should further investigate both time- and dose-dependent effects of combination therapies across all categories of prevention of lung cancer. https://bit.ly/3hlYTtY

Detalles Bibliográficos
Autores principales: Frille, Armin, Costantini, Adrien, Sreter, Katherina B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2021
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8291908/
https://www.ncbi.nlm.nih.gov/pubmed/34295419
http://dx.doi.org/10.1183/20734735.0325-2020
Descripción
Sumario:Given the poor survival of lung cancer patients and the promising observations herein, future studies (RCTs) should further investigate both time- and dose-dependent effects of combination therapies across all categories of prevention of lung cancer. https://bit.ly/3hlYTtY

Ejemplares similares